(VCBeat) Apr. 19, 2021 -- Suzhou Vivest Medical Technology Co., Ltd. ("Vivest Medical")  announced closing a Series A funding round of nearly 100 million yuan, led by Northern Light Venture Capital, with participation from Broad Vision Funds and Bluesail Medical. Proceeds from this round will be used for new product R&D, registration, mass production and marketing.

Founded in 2019 by Mr. Zheng Jie and its founding team, Vivest Medical is an innovative medical technology company focusing on the prevention and treatment of ventricular arrhythmias and cardiac rhythm data services. For malignant arrhythmias, Vivest Medical is committed to providing the world's leading comprehensive solution from prevention, monitoring, treatment, to rehabilitation, and creating a platform for the non-invasive prevention and treatment of ventricular arrhythmias and sudden cardiac death.

Up to now, Vivest Medical has developed wearable cardioverter defibrillator (WCD) and automatic external defibrillator based on its technology and innovation capability. According to reports, Vivest Medical has the completely independent intellectual property rights of two products. Its WCD is the first of its kind in China.

On January 7, 2021, the WCD was approved by the Center for Medical Device Evaluation of the National Medical Products Administration (NMPA) for its innovation and urgent clinical needs and entered the special evaluation procedure for innovative medical devices.

Founded in 2005, Northern Light is a venture capital firm targeting early-stage opportunities of innovation and disruptive technology. The company manages 5 USD funds and 5 RMB funds with a total amount of US$4.5 billion. Northern Light focuses on 3 main sectors including TMT, advanced technology, and healthcare.

Broad Vision Funds is a professional private equity investor, focusing on the investment of high-quality companies in the growth stage of China. The core team is composed of former executives from top investment companies such as Hony Capital and KKR, with nearly 15 years of experience in domestic and overseas equity investment on average. Broad Vision Fund invests in advanced manufacturing and healthcare industries.